Cargando…
Efficacy and Clinical Value of Liraglutide for Treatment of Diabetes Mellitus Complicated by Non-Alcoholic Fatty Liver Disease
BACKGROUND: The aim of this study was to investigate the efficacy and clinical value of liraglutide for the treatment of patients with diabetes mellitus (DM) complicated by non-alcoholic fatty liver disease (NAFLD). MATERIAL/METHODS: Patients with DM complicated by NAFLD (n=835) were enrolled. Patie...
Autores principales: | Zhang, Zhongyong, Qi, Yueying, Kong, Wubao, Jin, Qianqian, Wang, Xiaoyun, Dong, Yanfang, Wang, Yuansong, Li, Huajun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
International Scientific Literature, Inc.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6199821/ https://www.ncbi.nlm.nih.gov/pubmed/30325900 http://dx.doi.org/10.12659/MSM.911062 |
Ejemplares similares
-
MiR-149 Compromises the Reactions of Liver Cells to Fatty Acid via its Polymorphism and Increases Non-Alcoholic Fatty Liver Disease (NAFLD) Risk by Targeting Methylene Tetrahydrofolate Reductase (MTHFR)
por: An, Xianchao, et al.
Publicado: (2017) -
Distinct Prognostic Values of Alcohol Dehydrogenase Family Members for Non-Small Cell Lung Cancer
por: Wang, Peng, et al.
Publicado: (2018) -
Long Chain Non-Coding RNA (lncRNA) HOTAIR Knockdown Increases miR-454-3p to Suppress Gastric Cancer Growth by Targeting STAT3/Cyclin D1
por: Jiang, Datong, et al.
Publicado: (2019) -
The p66shc-mediated Regulation of Hepatocyte Senescence Influences Hepatic Steatosis in Nonalcoholic Fatty Liver Disease
por: Zhang, Jing, et al.
Publicado: (2020) -
Prognostic Value of Dynactin mRNA Expression in Cutaneous Melanoma
por: Wang, Qiaoqi, et al.
Publicado: (2018)